These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

185 related articles for article (PubMed ID: 3591904)

  • 21. Effects of STZ-induced diabetes and its treatment with vanadyl sulphate on cyclosporine A-induced nephrotoxicity in rats.
    Saad SY; Najjar TA
    Arch Toxicol; 2005 Sep; 79(9):493-9. PubMed ID: 15940472
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Effect of short-term cyclosporine A administration on urinary acidification.
    Batlle DC; Gutterman C; Tarka J; Prasad R
    Clin Nephrol; 1986; 25 Suppl 1():S62-9. PubMed ID: 3011339
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Normal renal function 8 to 13 years after cyclosporin A therapy in 285 diabetic patients.
    Assan R; Blanchet F; Feutren G; Timsit J; Larger E; Boitard C; Amiel C; Bach JF
    Diabetes Metab Res Rev; 2002; 18(6):464-72. PubMed ID: 12469360
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Experimental model of lead nephropathy. I. Continuous high-dose lead administration.
    Khalil-Manesh F; Gonick HC; Cohen AH; Alinovi R; Bergamaschi E; Mutti A; Rosen VJ
    Kidney Int; 1992 May; 41(5):1192-203. PubMed ID: 1614034
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Renal dysfunction in animal models of cyclosporine toxicity.
    Paller MS; Murray BM
    Transplant Proc; 1985 Aug; 17(4 Suppl 1):155-9. PubMed ID: 3895656
    [No Abstract]   [Full Text] [Related]  

  • 26. Influence of cyclosporine A on adaptive hypertrophy after unilateral nephrectomy in the rat.
    Schurek HJ; Neumann KH; Jesinghaus WP; Aeikens B; Wonigeit K
    Clin Nephrol; 1986; 25 Suppl 1():S144-7. PubMed ID: 3708925
    [TBL] [Abstract][Full Text] [Related]  

  • 27. In vivo and in vitro rat model for cyclosporine-induced proximal tubular toxicity.
    Berty RM; Adler S
    J Lab Clin Med; 1991 Jul; 118(1):17-25. PubMed ID: 2066638
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Focal glomerulosclerosis and nephron atrophy in rats on long-term cyclosporine treatment.
    Bäckman L; Sundelin B; Bohman SO
    APMIS Suppl; 1988; 4():27-36. PubMed ID: 3224023
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Nephrotoxicity of FK-506 in the rat. Studies on glomerular and tubular function, and on the relationship between efficacy and toxicity.
    Nielsen FT; Leyssac PP; Kemp E; Starklint H; Dieperink H
    Nephrol Dial Transplant; 1995; 10(3):334-40. PubMed ID: 7540737
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Cyclosporine nephrotoxicity in the Fischer rat.
    Verani R
    Clin Nephrol; 1986; 25 Suppl 1():S9-13. PubMed ID: 3708942
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Enhanced renal allograft rejection by inhibitors of nitric oxide synthase: a nonimmunologic influence on alloreactivity.
    Stojanovic T; Gröne HJ; Gieseler RK; Klanke B; Schlemminger R; Tsikas D; Gröne EF
    Lab Invest; 1996 Feb; 74(2):496-512. PubMed ID: 8780167
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [An investigation of cyclosporine A (CyA) nephrotoxicity by lithium clearance].
    Takei K
    Nihon Hinyokika Gakkai Zasshi; 1992 Jan; 83(1):40-7. PubMed ID: 1564825
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Effect of nifedipine on renal haemodynamics in an animal model of cyclosporin A nephrotoxicity.
    McNally PG; Baker F; Mistry N; Walls J; Feehally J
    Clin Sci (Lond); 1990 Sep; 79(3):259-66. PubMed ID: 2169375
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Antagonist capacities of nifedipine, captopril, phenoxybenzamine, prostacyclin and indomethacin on cyclosporin A induced impairment of rat renal function.
    Dieperink H; Leyssac PP; Starklint H; Jørgensen KA; Kemp E
    Eur J Clin Invest; 1986 Dec; 16(6):540-8. PubMed ID: 3104056
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Renal side-effects of cyclosporin A.
    Mason J
    Br J Dermatol; 1990 Jun; 122 Suppl 36():71-7. PubMed ID: 2369570
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Effect of thromboxane synthetase inhibition and angiotensin converting enzyme inhibition on acute cyclosporin A nephrotoxicity.
    Grieve EM; Hawksworth GM; Simpson JG; Whiting PH
    Biochem Pharmacol; 1990 Nov; 40(10):2323-9. PubMed ID: 2244933
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Morphometrical analysis of glomerular changes induced by cyclosporine in the rat.
    Perico N; Remuzzi A; Imberti O; Cavallotti D; Bertani T; Remuzzi G
    Am J Kidney Dis; 1991 May; 17(5):537-43. PubMed ID: 2024655
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The synthetic prostaglandin E1 analogue rioprostil reduces the nephrotoxic potential of cyclosporine A.
    Metz-Kurschel U; Wagner K; Mueller MK
    Transplant Proc; 1990 Aug; 22(4):1713-6. PubMed ID: 1975139
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The effect of chronic renal insufficiency on cyclosporine nephrotoxicity.
    Kinzler GJ; Holmes EW; Reckard CR; Jablokow VR; Fresco R; Flanigan RC
    J Urol; 1991 Jan; 145(1):179-83. PubMed ID: 1984088
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Enhancement of high dose cyclosporin A toxicity by frusemide.
    Whiting PH; Cunningham C; Thomson AW; Simpson JG
    Biochem Pharmacol; 1984 Apr; 33(7):1075-9. PubMed ID: 6712718
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.